-
公开(公告)号:US20230064983A1
公开(公告)日:2023-03-02
申请号:US17934553
申请日:2022-09-22
发明人: Stephan SIEGEL , Franziska SIEGEL , Volker SCHULZE , Markus BERGER , Jeremie Xavier G. MORTIER , Detlev SÜLZLE , Ulf BÖMER , Daniel KORR , Jens SCHRÖDER , Ursula MÖNNING , Michael NIEHUES , Matthew MEYERSON , Heidi GREULICH , Bethany KAPLAN
IPC分类号: A61K31/444 , C07D471/04 , A61K31/5377 , A61K31/4545 , A61K45/06
摘要: Compounds of formula (I) processes for their production and their use as pharmaceuticals.
-
公开(公告)号:US20240307362A1
公开(公告)日:2024-09-19
申请号:US17605956
申请日:2020-04-22
发明人: Stephan SIEGEL , Franziska SIEGEL , Volker SCHULZE , Markus BERGER , Keith GRAHAM , Stefan Nikolaus GRADL , Detlev SÜLZLE , Ulf BÖMER , Daniel KORR , Jens SCHRÖDER , Ursula MÖNNING , Michael NIEHUES , Matthew MEYERSON , Heidi GREULICH , Bethany KAPLAN , Hassan Youssef HARB , Phi Manh DINH
IPC分类号: A61K31/444 , A61K45/06 , A61P35/00 , C07D471/04 , C12Q1/6886 , G01N33/574
CPC分类号: A61K31/444 , A61K45/06 , A61P35/00 , C07D471/04 , C12Q1/6886 , G01N33/57484 , C12Q2600/106 , C12Q2600/156 , G01N2333/71
摘要: Compounds of formula (I), processes for their production and their use as pharmaceuticals are described herein.
-
公开(公告)号:US20230416249A1
公开(公告)日:2023-12-28
申请号:US18315472
申请日:2023-05-10
申请人: Bayer Aktiengesellschaft , Bayer Pharma Aktiengesellschaft , The Broad Institute, Inc. , Dana-Farber Cancer Institute, Inc.
发明人: Stephan SIEGEL , Franziska SIEGEL , Volker SCHULZE , Markus BERGER , Keith GRAHAM , Ulrich KLAR , Jeremie Xavier G. MORTIER , Detlev SÜLZLE , Ulf BÖMER , Daniel KORR , Jens SCHRÖDER , Matthew MEYERSON , Heidi GREULICH , Bethany KAPLAN
IPC分类号: C07D471/04 , A61P35/00 , G01N33/574
CPC分类号: C07D471/04 , A61P35/00 , G01N33/57492 , G01N2333/71
摘要: Compounds of formula (I)
processes for their production and their use as pharmaceuticals.-
公开(公告)号:US20220378762A1
公开(公告)日:2022-12-01
申请号:US17605990
申请日:2020-04-22
发明人: Franziska SIEGEL , Daniel KORR , Jens SCHRÖDER , Stephan SIEGEL , Heidi GREULICH , Bethany KAPLAN , Matthew MEYERSON
IPC分类号: A61K31/444 , A61K38/17 , A61K45/06 , A61P35/00 , C07D471/04 , A61K31/5377 , A61K31/4545
摘要: Compounds of formula (I) for use in the treatment or prophylaxis of a disease, which is a hyperproliferative disease and/or a disorder responsive to induction of cell death, selected from a haematological tumour, a solid tumour and/or metastases thereof, said tumour harbouring a mutant EGFR with exon 19 or 21 mutations, and their use as pharmaceuticals.
-
公开(公告)号:US20220298157A1
公开(公告)日:2022-09-22
申请号:US17605975
申请日:2020-04-22
发明人: Stephan SIEGEL , Franziska SIEGEL , Volker SCHULZE , Markus BERGER , Keith GRAHAM , Detlev SÜLZLE , Ulf BÖMER , Daniel KORR , Jens SCHRÖDER , Ursula MÖNNING , Michael NIEHUES , Matthew MEYERSON , Heidi GREULICH , Bethany KAPLAN
IPC分类号: C07D471/04 , A61K31/437 , A61K45/06 , A61K31/5377 , A61P35/00
摘要: Compounds of formula (I), formula (I), processes for their production and their R use as pharmaceuticals.
-
-
-
-